Does DABIGATRAN ETEXILATE Cause Peripheral swelling? 185 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 185 reports of Peripheral swelling have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.5% of all adverse event reports for DABIGATRAN ETEXILATE.
185
Reports of Peripheral swelling with DABIGATRAN ETEXILATE
0.5%
of all DABIGATRAN ETEXILATE reports
6
Deaths
64
Hospitalizations
How Dangerous Is Peripheral swelling From DABIGATRAN ETEXILATE?
Of the 185 reports, 6 (3.2%) resulted in death, 64 (34.6%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 185 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Peripheral swelling Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB